In addition, immune checkpoint inhibitors like CTLA-4, the PD-1/PD-L1 axis, and CD40 could overcome the suppressive microenvironment of the tumour, and prevent T cell exhaustion and apoptosis [33, 41–43]. Here, CD40 is linked to neoplasm.